halofuginone






122 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
101 32457283 Involvement of eIF2α in halofuginone-driven inhibition of TGF-β1-induced EMT. J Biosci 2020 2
102 32611237 Glutamyl-Prolyl-tRNA Synthetase Regulates Proline-Rich Pro-Fibrotic Protein Synthesis During Cardiac Fibrosis. Circ Res 2020 Aug 28 4
103 32679143 RETRACTED: Significance of halofuginone in esophageal squamous carcinoma cell apoptosis through HIF-1α-FOXO3a pathway. Life Sci 2020 Sep 15 2
104 32707492 Halofuginone inhibits LPS-induced attachment of monocytes to HUVECs. Int Immunopharmacol 2020 Oct 10
105 32818215 A high throughput screen for TMPRSS2 expression identifies FDA-approved and clinically advanced compounds that can limit SARS-CoV-2 entry. Res Sq 2020 Aug 14 4
106 33154782 Halofuginone inhibits tumorigenic progression of 5-FU-resistant human colorectal cancer HCT-15/FU cells by targeting miR-132-3p <i>in vitro</i>. Oncol Lett 2020 Dec 1
107 33259259 Halofuginone functions as a therapeutic drug for chronic periodontitis in a mouse model. Int J Immunopathol Pharmacol 2020 Jan-Dec 3
108 33433355 Halofuginone regulates keloid fibroblast fibrotic response to TGF-β induction. Biomed Pharmacother 2021 Mar 3
109 33729485 Targeting Nrf2-antioxidant signalling reverses acquired cabazitaxel resistance in prostate cancer cells. J Biochem 2021 Sep 22 3
110 33791697 The Prolyl-tRNA Synthetase Inhibitor Halofuginone Inhibits SARS-CoV-2 Infection. bioRxiv 2021 Mar 26 5
111 33799176 Inhibitors of aminoacyl-tRNA synthetases as antimycobacterial compounds: An up-to-date review. Bioorg Chem 2021 May 2
112 34162861 A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry. Nat Commun 2021 Jun 23 4
113 34209117 Differential Effects of Halofuginone Enantiomers on Muscle Fibrosis and Histopathology in Duchenne Muscular Dystrophy. Int J Mol Sci 2021 Jun 30 1
114 34321315 Nuclear Factor Erythroid 2-Related Factor 2 Depletion Sensitizes Pancreatic Cancer Cells to Gemcitabine via Aldehyde Dehydrogenase 3a1 Repression. J Pharmacol Exp Ther 2021 Oct 6
115 34401503 Effects of corticosteroids vs halofuginone on vocal fold wound healing in an ovine model. Laryngoscope Investig Otolaryngol 2021 Aug 5
116 34405694 Antifibrotic Therapy Augments the Antitumor Effects of Vesicular Stomatitis Virus Via Reprogramming Tumor Microenvironment. Hum Gene Ther 2022 Mar 1
117 34628069 Halofuginone enhances the anti-tumor effect of ALA-PDT by suppressing NRF2 signaling in cSCC. Photodiagnosis Photodyn Ther 2022 Mar 1
118 34901018 Halofuginone Sensitizes Lung Cancer Organoids to Cisplatin <i>via</i> Suppressing PI3K/AKT and MAPK Signaling Pathways. Front Cell Dev Biol 2021 2
119 34954499 Inhibition of GCN2 alleviates hepatic steatosis and oxidative stress in obese mice: Involvement of NRF2 regulation. Redox Biol 2022 Feb 3
120 35466425 Cellular responses to halofuginone reveal a vulnerability of the GCN2 branch of the integrated stress response. EMBO J 2022 Jun 1 4
121 35618180 Halofuginone micelle nanoparticles eradicate Nrf2-activated lung adenocarcinoma without systemic toxicity. Free Radic Biol Med 2022 Jul 2
122 35636724 Prospects of halofuginone as an antiprotozoal drug scaffold. Drug Discov Today 2022 May 27 1